Virtus ETF Advisers LLC - CTI BIOPHARMA CORP ownership

Back to all holdings Add to watchlist

CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Links
Filings
External links
Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2023$220,382
-28.9%
52,472
+1.8%
0.12%
-25.3%
Q4 2022$309,767
+22.9%
51,542
+18.8%
0.16%
+62.0%
Q3 2022$252,000
-1.2%
43,370
+1.5%
0.10%
+5.3%
Q2 2022$255,000–42,735–0.10%–
 Download
Other shareholders
CTI BIOPHARMA CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Legal & General Group Plc 9,340$84,9010.00%
UBS ASSET MANAGEMENT AMERICAS INC 92,700$389,3400.00%
FNY Investment Advisers, LLC 20$00.00%
View complete list of CTI BIOPHARMA CORP shareholders